Your browser is no longer supported. Please, upgrade your browser.
Settings
CDNA CareDx, Inc daily Stock Chart
CDNA [NASD]
CareDx, Inc
Index- P/E- EPS (ttm)-0.48 Insider Own2.00% Shs Outstand42.82M Perf Week-0.11%
Market Cap1.70B Forward P/E83.81 EPS next Y0.42 Insider Trans-21.53% Shs Float40.60M Perf Month5.42%
Income-20.30M PEG- EPS next Q-0.04 Inst Own93.40% Short Float14.10% Perf Quarter62.81%
Sales139.50M P/S12.19 EPS this Y60.30% Inst Trans5.23% Short Ratio8.74 Perf Half Y77.91%
Book/sh2.37 P/B14.85 EPS next Y2200.00% ROA-13.60% Target Price41.33 Perf Year-10.95%
Cash/sh0.67 P/C52.79 EPS next 5Y20.00% ROE-20.70% 52W Range13.04 - 41.27 Perf YTD63.19%
Dividend- P/FCF- EPS past 5Y-52.30% ROI-22.80% 52W High-14.71% Beta1.06
Dividend %- Quick Ratio2.10 Sales past 5Y36.00% Gross Margin65.50% 52W Low169.94% ATR1.95
Employees306 Current Ratio2.30 Sales Q/Q47.70% Oper. Margin-17.80% RSI (14)58.22 Volatility4.68% 5.95%
OptionableYes Debt/Eq0.00 EPS Q/Q24.90% Profit Margin-14.50% Rel Volume0.50 Prev Close35.69
ShortableYes LT Debt/Eq0.00 EarningsApr 30 AMC Payout- Avg Volume655.37K Price35.20
Recom1.50 SMA206.38% SMA5012.19% SMA20041.96% Volume329,085 Change-1.37%
Jun-26-20Initiated BTIG Research Buy $40
Jun-19-20Reiterated H.C. Wainwright Buy $40 → $37
Oct-01-19Resumed Craig Hallum Buy $48
May-09-19Upgrade H.C. Wainwright Neutral → Buy $30 → $43
Feb-15-19Initiated Jefferies Buy $35
Oct-23-18Resumed Raymond James Strong Buy $30
Sep-18-18Reiterated H.C. Wainwright Neutral $17 → $22
Nov-27-17Initiated H.C. Wainwright Buy $12
Jun-14-16Reiterated Mizuho Buy $12 → $8
Sep-29-15Downgrade Raymond James Outperform → Mkt Perform
Sep-25-15Initiated Craig Hallum Buy
Mar-18-15Reiterated Mizuho Buy $15 → $12
Jun-29-20 01:29PM  
Jun-24-20 04:12PM  
Jun-22-20 07:00AM  
Jun-18-20 04:05PM  
07:00AM  
Jun-15-20 04:05PM  
Jun-10-20 08:12PM  
Jun-09-20 05:13PM  
08:00AM  
Jun-08-20 05:00PM  
Jun-04-20 07:00AM  
May-28-20 07:00AM  
May-27-20 07:00AM  
May-15-20 07:00AM  
May-14-20 08:15AM  
May-07-20 07:00AM  
May-05-20 07:00AM  
May-02-20 08:35AM  
May-01-20 01:00PM  
Apr-30-20 04:05PM  
Apr-27-20 07:00AM  
Apr-23-20 12:32PM  
07:00AM  
Apr-22-20 07:00AM  
Apr-21-20 07:00AM  
Apr-14-20 07:00AM  
Apr-09-20 07:00AM  
Apr-08-20 04:01PM  
Apr-06-20 07:00AM  
Apr-02-20 06:44AM  
Mar-25-20 12:46AM  
Mar-20-20 07:00AM  
01:05AM  
Mar-17-20 10:10AM  
08:48AM  
07:00AM  
Mar-12-20 07:00AM  
Mar-05-20 07:00AM  
Feb-28-20 07:00AM  
Feb-27-20 04:05PM  
06:11AM  
Feb-26-20 07:00AM  
Feb-20-20 12:31PM  
Feb-19-20 11:18AM  
Feb-18-20 08:47AM  
Feb-13-20 07:00AM  
Feb-11-20 07:00AM  
Feb-07-20 12:00PM  
Feb-06-20 09:16AM  
Feb-04-20 08:15AM  
07:00AM  
Feb-03-20 11:54AM  
06:55AM  
Jan-22-20 04:44PM  
06:15AM  
Jan-13-20 07:00AM  
Jan-10-20 07:00AM  
Jan-09-20 07:00AM  
Jan-08-20 07:00AM  
Dec-24-19 07:00AM  
Dec-23-19 02:38PM  
Dec-17-19 05:28AM  
Dec-07-19 12:26PM  
Nov-19-19 07:00AM  
Nov-11-19 08:36AM  
Nov-06-19 12:19PM  
07:00AM  
Nov-04-19 07:00AM  
Nov-01-19 09:00AM  
07:38AM  
Oct-31-19 04:05PM  
Oct-26-19 12:48PM  
Oct-18-19 10:09AM  
Oct-17-19 08:00AM  
Oct-12-19 09:25AM  
Oct-07-19 10:20AM  
Sep-26-19 09:25AM  
Sep-24-19 08:00AM  
Sep-23-19 08:00AM  
Sep-20-19 08:00AM  
Sep-18-19 08:00AM  
Sep-17-19 08:00AM  
Sep-12-19 08:00AM  
07:41AM  
Sep-11-19 04:01PM  
Aug-28-19 08:00AM  
Aug-27-19 08:00AM  
Aug-22-19 09:48AM  
Aug-21-19 08:00AM  
Aug-09-19 01:45PM  
Aug-08-19 07:16PM  
Aug-05-19 09:30PM  
11:40AM  
06:06AM  
Aug-03-19 09:15AM  
Aug-02-19 01:31AM  
Aug-01-19 04:01PM  
Jul-30-19 08:10PM  
12:32PM  
11:44AM  
CareDx, Inc., a precision medicine company, discovers, develops, and commercializes healthcare solutions for transplant patients and caregivers worldwide. It offers AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; and AlloMap Heart, a gene expression solution for heart transplant patients. The company also develops, manufactures, markets, and sells products that increase the chance of successful transplants by facilitating a match between a donor and a recipient of stem cells and solid organs. In addition, it offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; Olerup SBT, a product range for sequence-based typing of HLA alleles; QTYPE that enables precision in HLA typing at a low to intermediate resolution for samples that uses real-time polymerase chain reaction methodology; and TruSight HLA, a solution for use in transplantation diagnostic testing. Further, the company provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Ottr, a transplant patient tracking software; and XynQAPI and Waitlist Management solutions. It offers its products directly to customers, as well as through third-party distributors. The company has a license agreement with Illumina, Inc. for the development, commercialization, and distribution of next generation sequencing product line for use in transplantation diagnostic testing; and Cibiltech SAS to commercialize KidneyCare iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Maag PeterChief Executive OfficerJul 06Option Exercise4.0010,00039,951431,974Jul 07 09:25 PM
Maag PeterChief Executive OfficerJul 06Sale34.2110,000342,098421,974Jul 07 09:25 PM
Maag PeterChief Executive OfficerJun 30Option Exercise2.309,26721,314400,156Jul 02 05:40 PM
Maag PeterChief Executive OfficerJun 30Sale35.0718,182637,719381,974Jul 02 05:40 PM
Maag PeterChief Executive OfficerJun 09Sale35.001,81863,630389,499Jun 11 07:44 PM
Maag PeterChief Executive OfficerJun 05Sale32.5850,0001,629,167391,317Jun 05 07:47 PM
King SashaChief Commercial OfficerJun 01Sale33.1025,402840,83928,334Jun 01 07:21 PM
Maag PeterChief Executive OfficerMay 19Sale32.2430,000967,122459,909May 19 06:16 PM
Bickerstaff GeorgeDirectorMay 13Sale27.6510,000276,45885,657May 13 05:28 PM
Goldberg MichaelDirectorMay 11Sale29.8610,000298,62880,765May 11 07:05 PM
HAGSTROM WILLIAM ADirectorMay 06Option Exercise1.2215,00018,30030,385May 07 07:29 PM
Bell Michael BrianChief Financial OfficerMay 06Option Exercise6.5735,816235,189134,229May 08 07:18 PM
Bell Michael BrianChief Financial OfficerMay 06Sale29.0057,1361,657,03277,093May 08 07:18 PM
HAGSTROM WILLIAM ADirectorMay 06Sale29.1215,000436,82915,385May 07 07:29 PM
Maag PeterChief Executive OfficerMar 16Sale17.3910,000173,873489,909Mar 16 08:48 PM
SNYDERMAN RALPHDirectorMar 03Option Exercise3.7014,59853,99879,901Mar 04 08:37 PM
Maag PeterChief Executive OfficerFeb 18Sale26.6210,000266,201451,909Feb 19 07:25 PM
King SashaChief Commercial OfficerFeb 14Sale26.017,390192,22148,502Feb 14 09:15 PM
Maag PeterChief Executive OfficerJan 15Sale23.1310,000231,300429,814Jan 16 08:16 PM
King SashaChief Commercial OfficerDec 09Sale21.972,12646,70848,709Dec 10 06:28 PM
HAGSTROM WILLIAM ADirectorDec 03Sale20.0612,500250,76115,385Dec 05 08:22 PM
Maag PeterChief Executive OfficerAug 06Sale28.8450,0001,441,834339,814Aug 08 04:10 PM
Cohen Fred EDirectorJul 11Option Exercise6.9615,765109,67271,279Jul 15 04:27 PM